Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

La NABP lanza el dominio genérico de alto nivel .pharmacy para ayudar a los consumidores a encontrar farmacias seguras en Internet
  • USA - English
  • USA - Français
  • USA - Deutsch
  • USA - español


News provided by

National Association of Boards of Pharmacy

Sep 10, 2014, 07:38 ET

Share this article

Share toX

Share this article

Share toX

MOUNT PROSPECT, Illinois, 10 de septiembre de 2014 /PRNewswire/ -- La National Association of Boards of Pharmacy® (NABP®) acaba de lanzar el dominio genérico de alto nivel (gTLD, por sus siglas en inglés) .pharmacy, con el propósito de suministrar a los consumidores de todo el mundo un medio para identificar en Internet a las farmacias y los recursos relacionados seguros, legales y éticos. De las decenas de miles de sitios inescrupulosos que venden fármacos de receta por Internet, la NABP ha revisado más de 10.800 y concluyó que casi el 97% no cumple con las leyes y los estándares establecidos para proteger la salud pública. Con esto en mente, la NABP concederá el uso del dominio .pharmacy únicamente a los operadores de sitios Web legítimos que cumplan con las leyes de farmacia en las jurisdicciones donde están basadas y en las cuales residen sus pacientes y clientes, de modo que los consumidores puedan encontrar fácilmente las farmacias seguras online.  

La primera etapa del registro de nombres para el dominio .pharmacy comenzará en noviembre de 2014. Esta fecha marca el comienzo del Período Sunrise – un período de inscripción preliminar y limitado para aquellos propietarios de marcas comerciales que han ingresado sus marcas comerciales en la Internet Corporation for Assigned Names and Numbers Trademark Clearinghouse (Corporación de Internet para los Nombres y Números Asignados por la Cámara Compensadora de Marcas Comerciales). Durante este período, los propietarios de marcas comerciales pueden solicitar a la NABP la aprobación para registrar el nombre de su marca comercial como un dominio .pharmacy.

Luego del Período Sunrise, la inscripción para los nombres de dominio .pharmacy estará abierta para los sitios Web de farmacias que estén acreditadas a través de los programas Verified Internet Pharmacy Practice Sites® (VIPPS®) y Veterinary-Verified Internet Pharmacy Practice Sites (Vet-VIPPS®) de la NABP, así como para los sitios Web de farmacias que han recibido la aprobación a través del programa e-Advertiser Approval de la NABP. Estas farmacias y sus sitios Web ya han pasado por un exigente proceso de revisión y han establecido su conformidad con los estándares de la NABP para una práctica online legítima, por lo que son consideradas elegibles para registrar un nombre de dominio .pharmacy.

Las solicitudes de otras farmacias que procuren registrar un nombre de dominio .pharmacy serán aceptadas a partir de comienzos de 2015. Esta etapa será seguida por el período de inscripción general (o disponibilidad general), el cual estará abierto para cualquier entidad que ofrezca productos, servicios o información relacionada a la farmacia y cumpla con los estándares de elegibilidad para .pharmacy. Las entidades que procuren un dominio .pharmacy deben primero enviar una solicitud a la NABP. Una vez aprobada, los solicitantes podrán registrar el dominio a través de un registrador autorizado.  

"Debido a que los vendedores inescrupulosos de fármacos continúan proliferando en Internet y distribuyendo medicamentos peligrosos, falsos y de baja calidad a los consumidores, el lanzamiento del programa .pharmacy es un paso importante para proteger la salud pública, tanto en EE.UU. como en otros países", afirmó el Presidente de la NABP, Joseph L. Adams, RPh. "La NABP tiene el placer de comenzar a ofrecer el registro en .pharmacy, de modo que los consumidores puedan determinar fácilmente si el sitio que están utilizando es de una farmacia legítima, con su licencia aprobada y operando de conformidad con el programa y los estándares regulatorios aplicables".

Con el apoyo de un comité asesor internacional y de la Federación Farmacéutica Internacional (FFI), la NABP ha desarrollado políticas y procedimientos para asegurar que únicamente los sitios Web que dispensen medicamentos legítimos y operen de un modo que resulte seguro y legal puedan usar un nombre de dominio .pharmacy. Los requisitos de elegibilidad para .pharmacy fueron desarrollados a efectos de abordar las preocupaciones compartidas por los interesados del ámbito doméstico e internacional, en lo que refiere a los vendedores ilegales de fármacos online que distribuyen productos que ponen en peligro la salud de los pacientes en todo el mundo.

Entre la coalición mundial de interesados que está detrás de la iniciativa .pharmacy se encuentran la Alliance for Safe Online Pharmacies, Eli Lilly and Company, la Alianza Europea para el Acceso a Medicamentos Seguros, la FFI, la Food and Drug Administration, Gilead Sciences, Inc., INTERPOL, Janssen Pharmaceuticals, Inc., LegitScript, Merck & Co. Inc., la National Association of Pharmacy Regulatory Authorities, Pfizer y los consejos estatales de farmacia.

Si desea más información acerca del programa gTLD .pharmacy, así como de la investigación más reciente de la NABP sobre los vendedores inescrupulosos de fármacos online, ingrese a www.dotpharmacy.net.

La NABP es la Asociación independiente, internacional e imparcial que ayuda a sus consejos y jurisdicciones estatales miembros con el propósito de proteger la salud pública.

FUENTE National Association of Boards of Pharmacy

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Pulse by NABP Product Verification Service Adopted by Regulators in 20 States, Including DEA

Pulse by NABP Product Verification Service Adopted by Regulators in 20 States, Including DEA

The National Association of Boards of Pharmacy® (NABP®) is pleased to announce that regulators in over 20 states, including Drug Enforcement...

More Releases From This Source

Explore

Internet Technology

Internet Technology

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.